Plasma amyloid assay as a pre-screening tool for amyloid positron emission tomography imaging in early stage Alzheimer’s disease
出版年份 2019 全文链接
标题
Plasma amyloid assay as a pre-screening tool for amyloid positron emission tomography imaging in early stage Alzheimer’s disease
作者
关键词
-
出版物
Alzheimers Research & Therapy
Volume 11, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-12-27
DOI
10.1186/s13195-019-0566-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- High performance plasma amyloid-β biomarkers for Alzheimer’s disease
- (2018) Akinori Nakamura et al. NATURE
- Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic
- (2018) Harald Hampel et al. Nature Reviews Neurology
- Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer’s disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database
- (2017) Fayçal Ben Bouallègue et al. Alzheimers Research & Therapy
- Plasma Levels of Aβ42 and Tau Identified Probable Alzheimer’s Dementia: Findings in Two Cohorts
- (2017) Lih-Fen Lue et al. Frontiers in Aging Neuroscience
- Diagnosing Dementia in the Clinical Setting: Can Amyloid PET Provide Additional Value Over Cerebrospinal Fluid?
- (2016) Philip S.J. Weston et al. JOURNAL OF ALZHEIMERS DISEASE
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2016) Jeff Sevigny et al. NATURE
- Florbetapir positron emission tomography and cerebrospinal fluid biomarkers
- (2015) Ann Hake et al. Alzheimers & Dementia
- Amyloid biomarkers in Alzheimer's disease
- (2015) Kaj Blennow et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Nonlinear Association Between Cerebrospinal Fluid and Florbetapir F-18 β-Amyloid Measures Across the Spectrum of Alzheimer Disease
- (2015) Jon B. Toledo et al. JAMA Neurology
- Targeting Prodromal Alzheimer Disease With Avagacestat
- (2015) Vladimir Coric et al. JAMA Neurology
- Plasma Aβ but Not Tau is Related to Brain PiB Retention in Early Alzheimer’s Disease
- (2014) Kai-Yuan Tzen et al. ACS Chemical Neuroscience
- Amyloid-β efflux from the central nervous system into the plasma
- (2014) Kaleigh Filisa Roberts et al. ANNALS OF NEUROLOGY
- Apolipoprotein E in Alzheimer's Disease: An Update
- (2014) Jin-Tai Yu et al. Annual Review of Neuroscience
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
- (2014) Bruno Dubois et al. LANCET NEUROLOGY
- ApoE and Aβ in Alzheimer’s Disease: Accidental Encounters or Partners?
- (2014) Takahisa Kanekiyo et al. NEURON
- Perspectives on future Alzheimer therapies: amyloid-β protofibrils - a new target for immunotherapy with BAN2401 in Alzheimer’s disease
- (2014) Lars Lannfelt et al. Alzheimers Research & Therapy
- The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI)
- (2014) Shannon Risacher Frontiers in Aging Neuroscience
- Combined Plasma Biomarkers for Diagnosing Mild Cognition Impairment and Alzheimer’s Disease
- (2013) Ming-Jang Chiu et al. ACS Chemical Neuroscience
- Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging
- (2013) Keith A. Johnson et al. Alzheimers & Dementia
- Comparing positron emission tomography imaging and cerebrospinal fluid measurements of β-amyloid
- (2013) Susan M. Landau et al. ANNALS OF NEUROLOGY
- Apolipoprotein E, gender, and Alzheimer’s disease: an overlooked, but potent and promising interaction
- (2013) Leo Ungar et al. Brain Imaging and Behavior
- Perfusion-like template and standardized normalization-based brain image analysis using 18F-florbetapir (AV-45/Amyvid) PET
- (2013) Ing-Tsung Hsiao et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
- (2013) Chia-Chen Liu et al. Nature Reviews Neurology
- Evaluating Amyloid-β Oligomers in Cerebrospinal Fluid as a Biomarker for Alzheimer’s Disease
- (2013) Mikko Hölttä et al. PLoS One
- National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
- (2012) Bradley T. Hyman et al. Alzheimers & Dementia
- Clinic Applications in Assaying Ultra-Low-Concentration Bio-Markers Using HTS SQUID-Based AC Magnetosusceptometer
- (2012) S. Y. Yang et al. IEEE TRANSACTIONS ON APPLIED SUPERCONDUCTIVITY
- Amyloid- assessed by florbetapir F 18 PET and 18-month cognitive decline: A multicenter study
- (2012) P. M. Doraiswamy et al. NEUROLOGY
- Biofunctionalized Magnetic Nanoparticles for Specifically Detecting Biomarkers of Alzheimer’s Disease in Vitro
- (2011) Che-Chuan Yang et al. ACS Chemical Neuroscience
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease
- (2011) Victor L. Villemagne et al. ANNALS OF NEUROLOGY
- Using Positron Emission Tomography and Florbetapir F 18 to Image Cortical Amyloid in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer Disease
- (2011) Adam S. Fleisher ARCHIVES OF NEUROLOGY
- Use of Florbetapir-PET for Imaging β-Amyloid Pathology
- (2011) Christopher M. Clark JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Amyloid and tau proteins in cortical brain biopsy and Alzheimer's disease
- (2010) Ville Leinonen et al. ANNALS OF NEUROLOGY
- Whole-body biodistribution and brain PET imaging with [18F]AV-45, a novel amyloid imaging agent — a pilot study
- (2010) Kun-Ju Lin et al. NUCLEAR MEDICINE AND BIOLOGY
- APOEpredicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging
- (2009) John C. Morris et al. ANNALS OF NEUROLOGY
- Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain
- (2009) Tero Tapiola et al. ARCHIVES OF NEUROLOGY
- Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy
- (2009) Guojun Bu NATURE REVIEWS NEUROSCIENCE
- Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease
- (2009) A. Drzezga et al. NEUROLOGY
- The Role of Apolipoprotein E in Alzheimer's Disease
- (2009) Jungsu Kim et al. NEURON
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started